Kynurenic Acid: Unveiling Its Impact on the Brain’s Neurotransmission and Neurological Disorders
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Signaling".
Deadline for manuscript submissions: 28 June 2024 | Viewed by 156
Special Issue Editors
Interests: kynurenine pathway metabolism; cognition; neurodegenerative disorders; schizophrenia
Interests: psychiatric and neurodegenerative disorders; cognition; kynurenine pathway; neurodevelopment; cannabinoids
Interests: kynurenines and bioenergetic; tryptophan catabolism modulation; psychiatric diseases; cognition; neurodegeneration; aging
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Kynurenic acid (KYNA), an endogenous neuromodulatory molecule derived from tryptophan catabolism, is increasingly understood to play major roles in CNS functions. KYNA can act on multiple biological targets, such as NMDA, α7nACh, GPR35 and aryl hydrocarbon receptors. In addition, recent novel findings suggest that KYNA could also modulate brain function by exerting antioxidant properties, interacting with the cannabinoid system and modulating gut microbiota. This has advanced our knowledge on the implications of KYNA in CNS functions, either under physiological or pathological conditions. Nevertheless, much remains to be explored regarding the role of KYNA during the normal aging process.
This Special Issue of Cells, ‘Kynurenic Acid: Unveiling Its Impact on the Brain's Neurotransmission and Neurological Disorders’, aims to collate recent preclinical and clinical studies on the relevance of KYNA in CNS, with special emphasis on the consequences of alterations in KYNA levels on neurotransmission and the importance of maintaining its physiological levels in neurological pathologies. This could shed light on the possible role of KYNA as a pathological biomarker and/or a therapeutic target for neurological disorder treatment/prevention. We invite you to submit either original research articles or reviews to this Special Issue.
Dr. Korrapati V. Sathyasaikumar
Dr. Sarah Beggiato
Dr. Verónica Pérez de la Cruz
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- kynurenic acid
- cognition
- aging
- neuromodulation
- neurodegeneration
- neurodevelopment
- neuroinflammation
- tryptophan catabolism
